JNK-IN-24 - CAS 2226808-28-0

JNK-IN-24 is a JNK inhibitor and an anti-metastatic cancer agent. It reduces the expression of JNK and MMP1 in cancer tissues induced by Scrib knockdown. JNK-IN-24 aids in the recovery of the ScribRNAi tumor disc phenotype and is applicable for studying various epithelial-derived cancers.

JNK, MMP

Proteases/Proteasome, MAPK

2226780

C19H17ClO5

360.79

O=C(OCC)C1=C(OC=2C=C(O)C=C(O)C2C1C3=CC=C(Cl)C=C3)C

-20°C

Ice Packs

Small Compound